Article
Chimeric antigen receptor transduced T cells: Tuning up for the next generation
9 Nov 2017
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has recently achieved impressive clinical outcome in patients with CD19-positive hematologic malignancies. Extrapolation of CAR T cell treatment to solid tumors, however, has not yet yielded similar results. This might be due to intrinsic causes, e.g. insufficient CAR T cell activation or CAR toxicity as well as extrinsic factors displaying an unfavorable tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
